SELLAS Life Sciences Group, Inc. — Director's Dealing 2012

Jul 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2012-06-15

Reporting Person: SCHWARTZ MARK W. (EVP Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-15	Common Stock, par value $0.0001	A	89322	—	Acquired	439907	Direct
2012-07-10	Common Stock, par value $0.0001	J	21902	$0.3995	Acquired	461809	Direct

Footnotes

F1: The shares shown were issued in escrow on February 15, 2012 for the account of the reporting person at a value of $0.76 per share in payment of contingent value rights held by the reporting person, subject to release of the shares from escrow upon approval of the issuance by the stockholders of Galena Biopharma, Inc. The Galena stockholders approved the issuance on June 15, 2012.

F2: Pursuant to the Issuer's Employee Stock Purchase Plan.